Cargando…

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions

BACKGROUND: The formation of alloantibodies directed against class I human leukocyte antigens (HLA) continues to be a clinically challenging complication after platelet transfusions, which can lead to platelet refractoriness (PR) and occurs in approximately 5%–15% of patients with chronic platelet s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Osch, Thijs L. J., Pongracz, Tamas, Geerdes, Dionne M., Mok, Juk Yee, van Esch, Wim J. E., Voorberg, Jan, Kapur, Rick, Porcelijn, Leendert, Kerkhoffs, Jean‐Louis H., van der Meer, Pieter F., van der Schoot, C. Ellen, de Haas, Masja, Wuhrer, Manfred, Vidarsson, Gestur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	PLATELETS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828502/ https://www.ncbi.nlm.nih.gov/pubmed/36165642 http://dx.doi.org/10.1111/jth.15898

Ejemplares similares

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)

Anti‐platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications
por: Schmidt, David E., et al.
Publicado: (2020)

Biological stratification of clinical disease courses in childhood immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2021)

Clinical characteristics of human platelet antigen (HPA)‐1a and HPA‐5b alloimmunised pregnancies and the association between platelet HPA‐5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia
por: de Vos, Thijs W., et al.
Publicado: (2021)

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia
por: Jolink, Anne-Tess C., et al.
Publicado: (2021)

Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia
por: Szittner, Zoltán, et al.
Publicado: (2023)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
por: Bye, Alexander P., et al.
Publicado: (2021)

Localized endothelial‐based control of platelet aggregation and coagulation under flow: A proof‐of‐principle vessel‐on‐a‐chip study
por: Brouns, Sanne L.N., et al.
Publicado: (2020)

A clinical prediction score for transient versus persistent childhood immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Removal of platelets from blood plasma to improve the quality of extracellular vesicle research
por: Bettin, Britta, et al.
Publicado: (2022)

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation
por: Sonneveld, Myrthe E., et al.
Publicado: (2017)

Antibody glycosylation in COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022)

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
por: Rijkers, Maaike, et al.
Publicado: (2018)

Cytohesin-2 phosphorylation by protein kinase C relieves the constitutive suppression of platelet dense granule secretion by ADP-ribosylation factor 6
por: van den Bosch, M T J, et al.
Publicado: (2014)

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
por: Einarsdottir, Helga K., et al.
Publicado: (2012)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018)

Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study
por: van Dijk, Wobke E. M., et al.
Publicado: (2021)

The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study
por: Ypma, Paula F., et al.
Publicado: (2019)

Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency
por: van Asten, Ivar, et al.
Publicado: (2019)

Dimeric FcγR ectodomains detect pathogenic anti‐platelet factor 4–heparin antibodies in heparin‐induced thromobocytopenia
por: Wines, B. D., et al.
Publicado: (2018)

Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study
por: de Vos, Thijs W., et al.
Publicado: (2021)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)
por: Zeeuw van der Laan, Eveline A.N., et al.
Publicado: (2020)

Anti‐platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review
por: Schmidt, David E., et al.
Publicado: (2020)

HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk
por: Winkelhorst, Dian, et al.
Publicado: (2020)

Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
por: Swinkels, Maurice, et al.
Publicado: (2022)

Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG
por: JAVELA, K, et al.
Publicado: (2007)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation
por: Moraes, L A, et al.
Publicado: (2010)

Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells
por: Moraes, L A, et al.
Publicado: (2010)

The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function
por: Holbrook, L-M, et al.
Publicado: (2012)

CLEC‐2‐dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP
por: Borgognone, A., et al.
Publicado: (2014)

Protein kinase Cε and protein kinase Cθ double-deficient mice have a bleeding diathesis
por: UNSWORTH, A J, et al.
Publicado: (2012)

Manipulating megakaryocytes to manufacture platelets ex vivo
por: Karagiannis, P, et al.
Publicado: (2015)

Akt and mitogen‐activated protein kinase enhance C‐type lectin‐like receptor 2‐mediated platelet activation by inhibition of glycogen synthase kinase 3α/β
por: Moroi, A. J., et al.
Publicado: (2015)

Modified platelet deposition on matrix metalloproteinase 13 digested collagen I
por: Howes, J.‐M., et al.
Publicado: (2015)

The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies
por: Phillips, E. H., et al.
Publicado: (2016)

Amplification of human platelet activation by surface pannexin-1 channels
por: Taylor, K A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3632m4qfv1vhh57045shr1bp1j